The global dlif & xlif implants market size is anticipated to reach USD 389.9 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.2% during the forecast period. Increasing prevalence of spinal cord injuries and diseases, growing adoption of minimally invasive surgical procedures, availability of technologically advanced products for spinal surgeries, and increasing obesity are augmenting the market.
Aging is one of the critical factors responsible for spine degeneration, which leads to instability and back pain. Thus, rising geriatric population worldwide is projected to increase the demand for DLIF and XLIF implants. These implants are minimally invasive procedures and are gaining popularity owing to their associated advantages such as reduction in duration of surgery and hospital stay, lower trauma and incisions, lower blood loss, reduced recovery time, and reduced damage to surrounding tissues & anatomical structures. DLIF and XLIF surgeries are, thus, considered viable options and being increasingly acknowledged by healthcare professionals.
On the basis of application, the DLIF and XLIF implants market has been classified into degenerative disc disease, spondylolisthesis, scoliosis, and other spinal disorders. In 2017, the degenerative disc diseases segment dominated the market with revenue of USD 129.1 million, while the scoliosis segment is poised to expand at the highest CAGR during the forecast period.
Degenerative disc disease is a common cause of back pain and a widespread public health issue. It is among the leading causes for disabilities that affect the general wellbeing of people and ability to perform activities in day-to-day life. Spiraling demand for spinal surgeries and increasing number of people opting for treatment for back pain are likely to drive the overall market.
North America dominated the market in 2017, owing to increasing spinal injuries, large base of geriatric population, and rising research activities for development of innovative spine approaches. Moreover, Asia Pacific is expected to witness the fastest growth at a CAGR of 9.3% over the forecast period, owing to continuous improvements in infrastructure and healthcare facilities and rising healthcare expenditure. Mounting cases of trauma and growing geriatric population are leading to increased prevalence of spinal cord injuries, thereby propelling the regional market. Furthermore, flourishing medical tourism in the region is benefitting the growth of the market.
Some of the significant market players are Medtronic; NuVasive, Inc.; Globus Medical, Inc.; Stryker Corporation; DePuy Synthes Companies; Orthofix Holdings, Inc.; and Zimmer Biomet. These companies focus on new product launches, technological innovations, and regional expansion to consolidate their position in the market.
Click the link below:
Further key findings from the report suggest:
- The scoliosis segment is estimated to exhibit the highest growth during the forecast period due to its increasing prevalence, improving diagnosis and treatment, and rising awareness regarding the treatment availability
- North America dominated the global market owing to increase in spinal cord injuries and presence of various organizations that create awareness in the region
- Asia Pacific is anticipated to post the highest CAGR of 9.4 % owing to booming medical tourism industry
- Some of the key players are Medtronic; NuVasive, Inc.; Globus Medical, Inc.; Stryker Corporation; DePuy Synthes Companies; Orthofix Holdings, Inc.; and Zimmer Biomet.